Diagnosis of new onset heart failure in the community: The importance of a shared-care approach and judicious use of BNP

Irish Journal of Medical Science

Volumn 177, Issue 3, 2008, Pages 197-203

  Mak, G ^a   Ryder, M ^a   Murphy, N F ^a   O'Loughlin, C ^a   McCaffrey, D ^a   Ledwidge, M ^a   McDonald, K ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

Author keywords

B type natriuretic peptide; Diagnosis; General practise; Heart failure

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; UREA;

AGED; ARTICLE; BLOOD CELL COUNT; COMMUNITY CARE; CONTROLLED STUDY; DELAYED DIAGNOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; ELECTROLYTE BLOOD LEVEL; FALSE NEGATIVE RESULT; FEMALE; GENERAL PRACTICE; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PATIENT CARE; PATIENT REFERRAL; REFERENCE VALUE; THORAX RADIOGRAPHY; UREA BLOOD LEVEL;

EID: 48549095049     PISSN: 00211265     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11845-008-0186-3     Document Type: Article

References (37)

1. Fuat A, Hungin AP, Murphy JJ (2003) Barriers to accurate diagnosis and effective management of heart failure in primary care: Qualitative study. BMJ 326(7382):196. doi: 10.1136/bmj.326.7382.196
2. Khunti K, Hearnshaw H, Baker R, Grimshaw G (2002) Heart failure in primary care: Qualitative study of current management and perceived obstacles to evidence-based diagnosis and management by general practitioners. Eur J Heart Fail 4(6):771-777. doi: 10.1016/ S1388-9842(02)00119-8
3. Sparrow N, Adlam D, Cowley A, Hampton JR (2003) The diagnosis of heart failure in general practice: Implications for the UK National Service Framework. Eur J Heart Fail 5(3):349-354. doi: 10.1016/ S1388-9842(03)00046-1
4. Zaphiriou A, Robb S, Murray-Thomas T et al (2005) The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail 7(4):537-541. doi: 10.1016/j.ejheart.2005.01.022
5. Fox KF, Cowie MR, Wood DA, Coats AJ, Poole-Wilson PA, Sutton GC (2000) A Rapid Access Heart Failure Clinic provides a prompt diagnosis and appropriate management of new heart failure presenting in the community. Eur J Heart Fail 2(4):423-429. doi: 10.1016/S1388-9842(00)00108-2
6. Shah S, Davies MK, Cartwright D, Nightingale P (2004) Management of chronic heart failure in the community: Role of a hospital based open access heart failure service. Heart 90(7):755-759. doi: 10.1136/ hrt.2002.006460
7. Atisha D, Bhalla MA, Morrison LK et al (2004) A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction. Am Heart J 148(3):518-523. doi: 10.1016/ j.ahj.2004.03.014
8. Fuat A, Murphy JJ, Hungin AP et al (2006) The diagnostic accuracy and utility of a B-type natriuretic peptide test in a community population of patients with suspected heart failure. Br J Gen Pract 56(526):327-333
9. O'Hanlon R, O'Shea P, Ledwidge M et al (2007) The biologic variability of B-type natriuretic peptide and N-terminal pro-B-type natriuretic peptide in stable heart failure patients. J Card Fail 13(1):50-55. doi: 10.1016/j.cardfail.2006.09.003
10. Ho KK, Pinsky JL, Kannel WB, Levy D (1993) The epidemiology of heart failure: The Framingham Study. J Am Coll Cardiol 22(4 Suppl A):6A-13A
11. The SOLVD Investigators (1992) Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. N Engl J Med 327(10):685-691
12. Wang CS, FitzGerald JM, Schulzer M, Mak E, Ayas NT (2005) Does this dyspneic patient in the emergency department have congestive heart failure? JAMA 294(15):1944-1956. doi: 10.1001/jama.294.15.1944
13. Mueller C, Frana B, Rodriguez D, Laule-Kilian K, Perruchoud AP (2005) Emergency diagnosis of congestive heart failure: Impact of signs and symptoms. Can J Cardiol 21(11):921-924
14. Stevenson LW, Perloff JK (1989) The limited reliability of physical signs for estimating hemodynamics in chronic heart failure. JAMA 261(6):884-888. doi: 10.1001/jama.261.6.884
15. Remes J, Miettinen H, Reunanen A, Pyorala K (1991) Validity of clinical diagnosis of heart failure in primary health care. Eur Heart J 12(3):315-321
16. Sim V, Hampton D, Phillips C et al (2003) The use of brain natriuretic peptide as a screening test for left ventricular systolic dysfunction-cost-effectiveness in relation to open access echocardiography. Fam Pract 20(5):570-574. doi: 10.1093/fampra/cmg513
17. Heidenreich PA, Gubens MA, Fonarow GC, Konstam MA, Stevenson LW, Shekelle PG (2004) Cost-effectiveness of screening with B-type natriuretic peptide to identify patients with reduced left ventricular ejection fraction. J Am Coll Cardiol 43(6):1019-1026. doi: 10.1016/ j.jacc.2003.10.043
18. Nielsen OW, McDonagh TA, Robb SD, Dargie HJ (2003) Retrospective analysis of the cost-effectiveness of using plasma brain natriuretic peptide in screening for left ventricular systolic dysfunction in the general population. J Am Coll Cardiol 41(1):113-120. doi: 10.1016/ S0735-1097(02)02625-6
19. Steg PG, Joubin L, McCord J et al (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128(1):21-29. doi: 10.1378/chest.128.1.21
20. Steg PG, Joubin L, McCord J et al (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128(1):21-29. doi: 10.1378/chest.128.1.21
21. Francis CM, Caruana L, Kearney P et al (1995) Open access echocardiography in management of heart failure in the community. BMJ 310(6980):634-636
22. Khunti K (2004) Systematic review of open access echocardiography for primary care. Eur J Heart Fail 6(1):79-83. doi: 10.1016/ j.ejheart.2003.10.002
23. Murphy JJ, Frain JP, Ramesh P, Siddiqui RN, Bossingham CM (1996) Open-access echocardiography to general practitioners for suspected heart failure. Br J Gen Pract 46(409):475-476
24. Fung JW, Yu CM, Yip G et al (2003) Effect of beta blockade (carvedilol or metoprolol) on activation of the renin-angiotensin-aldosterone system and natriuretic peptides in chronic heart failure. Am J Cardiol 92(4):406-410. doi: 10.1016/S0002-9149(03)00658-1
25. Johnson W, Omland T, Hall C et al (2002) Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure. J Am Coll Cardiol 39(10):1623-1629. doi: 10.1016/S0735-1097(02)01814-4
26. Murdoch DR, McDonagh TA, Byrne J et al (1999) Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy. Am Heart J 138(6Pt 1):1126-1132. doi: 10.1016/S0002-8703(99)70079-7
27. Yoshimura M, Mizuno Y, Nakayama M et al (2002) B-type natriuretic peptide as a marker of the effects of enalapril in patients with heart failure. Am J Med 112(9):716-720. doi: 10.1016/S0002-9343(02)01121-X
28. Bayes-Genis A, Lloyd-Jones DM, van Kimmenade RR et al (2007) Effect of body mass index on diagnostic and prognostic usefulness of amino-terminal pro-brain natriuretic peptide in patients with acute dyspnea. Arch Intern Med 167(4):400-407. doi: 10.1001/archinte.167.4.400
29. Daniels LB, Clopton P, Bhalla V et al (2006) How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly multinational study. Am Heart J 151(5):999-1005. doi: 10.1016/j.ahj.2005.10.011
30. Wang TJ, Larson MG, Levy D et al (2004) Impact of obesity on plasma natriuretic peptide levels. Circulation 109(5):594-600. doi: 10.1161/ 01.CIR.0000112582.16683.EA
31. Krauser DG, Lloyd-Jones DM, Chae CU et al (2005) Effect of body mass index on natriuretic peptide levels in patients with acute congestive heart failure: A ProBNP investigation of dyspnea in the Emergency department (PRIDE) substudy. Am Heart J 149(4):744-750. doi: 10.1016/ j.ahj.2004.07.010
32. Maisel AS, McCord J, Nowak RM et al (2003) Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly multinational study. J Am Coll Cardiol 41(11):2010-2017. doi: 10.1016/ S0735-1097(03)00405-4
33. http://www.fda.gov/cdrh/ode/guidance/1072.html. 30/11/2000. Internet Communication
34. Zaphiriou A, Robb S, Murray-Thomas T et al (2005) The diagnostic accuracy of plasma BNP and NTproBNP in patients referred from primary care with suspected heart failure: Results of the UK natriuretic peptide study. Eur J Heart Fail 7(4):537-541. doi: 10.1016/j.ejheart.2005.01.022
35. McCullough PA, Nowak RM, McCord J et al (2002) B-type natriuretic peptide and clinical judgment in emergency diagnosis of heart failure: analysis from breathing not properly (BNP) multinational study. Circulation 106(4):416-422. doi: 10.1161/01.CIR.0000025242.79963.4C
36. Steg PG, Joubin L, McCord J et al (2005) B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. Chest 128(1):21-29. doi: 10.1378/chest.128.1.21
37. Nielsen OW, Cowburn PJ, Sajadieh A, Morton JJ, Dargie H, McDonagh T (2007) Value of BNP to estimate cardiac risk in patients on cardioactive treatment in primary care. Eur J Heart Fail 9(12):1178-1185. doi: 10.1016/j.ejheart.2007.10.004